Biblio
Export 1381 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is G [Clear All Filters]
“The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.”, J Alzheimers Dis, vol. 60, no. 2, pp. 341-347, 2017.
, “The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.”, J Alzheimers Dis, vol. 60, no. 2, pp. 341-347, 2017.
, “Effects of Exercise on Cognitive Function in Older People with Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 1, pp. 323-332, 2017.
, “The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 327-334, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1271-1278, 2017.
, “Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.”, J Alzheimers Dis, vol. 56, no. 1, pp. 129-143, 2017.
, “The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
, “The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
, “Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.”, J Alzheimers Dis, vol. 58, no. 1, pp. 123-137, 2017.
, “Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 2, pp. 289-301, 2017.
, “Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1213-1226, 2017.
, “Exploring Potential Electrophysiological Biomarkers in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1283-1292, 2017.
, “Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1183-1193, 2017.
, “Frequency-Dependent Changes in the Amplitude of Low-Frequency Fluctuations in Mild Cognitive Impairment with Mild Depression.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1175-1187, 2017.
, “Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1185-1189, 2017.
, “Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's ”, J Alzheimers Dis, vol. 60, no. 1, pp. 151-164, 2017.
, “Functional Connectivity in the Default Mode Network is Reduced in Association with Nocturnal Awakening in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1373-1384, 2017.
, “Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 165-181, 2017.
, “Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.”, J Alzheimers Dis, vol. 55, no. 1, pp. 249-258, 2017.
, “Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.”, J Alzheimers Dis, vol. 55, no. 1, pp. 249-258, 2017.
, “Glutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 59, no. 2, pp. 537-541, 2017.
,